The 2019 global health multilateral calendar kicked off as it always does with the World Health Organization (WHO) Executive Board (EB) meeting in late January in Geneva. This year’s session featured a packed agenda with significant implications for research and development.
Matthew Robinson, MA
Policy and Advocacy Officer
Blog posts written by Matthew
Total of 22 blog posts
Health ministers of the G20 nations, representing the world’s leading economies, met earlier this month in Mar del Plata, Argentina to chart a course of action on global health for the upcoming year.
What global health research advocates need to know about the 71st World Health Assembly (WHA).
The 71st session of the World Health Assembly will see a number of debates that could impact global health R&D. Here is is what you need to know.
Last week’s World Health Organization (WHO) Executive Board meeting featured agenda items on access to medicines and intellectual property. We cover how debates on these items shook out:
A busy week at the 72nd United Nations General Assembly winds to a close with key discussions surrounding the global economic returns of health R&D.